| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |